OM Delmonte,C Oguz,K Dobbs,K Myint-Hpu,B Palterer,MS Abers,D Draper,M Truong,IM Kaplan,RM Gittelman,Y Zhang,LB Rosen,AL Snow,CL Dalgard,PD Burbelo,L Imberti,A Sottini,E Quiros-Roldan,F Castelli,C Rossi,D Brugoni,A Biondi,LR Bettini,D'Angio' Zhang,P Bonfanti,MV Anderson,A Saracino,M Chironna,M Di Stefano,JR Fiore,T Santantonio,R Castagnoli,GL Marseglia,M Magliocco,M Bosticardo,F Pala,E Shaw,H Matthrews,SE Weber,S Xirasagar,J Barnett,AJ Oler,D Dimitrova,JRE Bergerson,DH McDermott,VK Rao,PM Murphy,SM Holland,A Lisco,HC Su,MS Lionakis,JI Cohen,AF Freeman,TM Snyder,J Lack,LD Notarangelo

Abstract:Background Functional T-cell responses are essential for virus clearance and long-term protection after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, whereas certain clinical factors, such as older age and immunocompromise, are associated with worse outcome. Objective We sought to study the breadth and magnitude of T-cell responses in patients with coronavirus disease 2019 (COVID-19) and in individuals with inborn errors of immunity (IEIs) who had received COVID-19 mRNA vaccine. Methods Using high-throughput sequencing and bioinformatics tools to characterize the T-cell receptor β repertoire signatures in 540 individuals after SARS-CoV-2 infection, 31 IEI recipients of COVID-19 mRNA vaccine, and healthy controls, we quantified HLA class I– and class II–restricted SARS-CoV-2–specific responses and also identified several HLA allele–clonotype motif associations in patients with COVID-19, including a subcohort of anti–type 1 interferon (IFN-1)-positive patients. Results Our analysis revealed that elderly patients with COVID-19 with critical disease manifested lower SARS-CoV-2 T-cell clonotype diversity as well as T-cell responses with reduced magnitude, whereas the SARS-CoV-2–specific clonotypes targeted a broad range of HLA class I– and class II–restricted epitopes across the viral proteome. The presence of anti–IFN-I antibodies was associated with certain HLA alleles. Finally, COVID-19 mRNA immunization induced an increase in the breadth of SARS-CoV-2–specific clonotypes in patients with IEIs, including those who had failed to seroconvert. Conclusions Elderly individuals have impaired capacity to develop broad and sustained T-cell responses after SARS-CoV-2 infection. Genetic factors may play a role in the production of anti–IFN-1 antibodies. COVID-19 mRNA vaccines are effective in inducing T-cell responses in patients with IEIs.

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

COVID-19-neutralizing antibodies predict disease severity and survival

Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection

COVID-19 neutralizing antibodies predict disease severity and survival

SARS-CoV-2 epitope-specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19

Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients

Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

Restrained memory CD8 T cell responses favors viral persistence and elevated IgG responses in patients with severe Long COVID

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2

High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection.

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Kinetics of viral load and antibody response in relation to COVID-19 severity

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients

Single-cell landscape of immunological responses in patients with COVID-19

Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants